Autopsy report · NCT01081938

Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition

“Recruitment challenges”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year before it stopped.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Sanofi

Sponsor type

Industry

Conditions

Diabetes Mellitus, Type 2

Interventions

INSULIN GLARGINE; INSULIN GLULISINE

Participants

15

Sites

10

Countries

Brazil

Trials that died the same way

• Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHD
  “challenge in recruitment” (95% match in meaning)
• GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
  “Anticipated recruitment challenges” (94% match in meaning)
• A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery
  “Recruitment issues” (90% match in meaning)
• Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus
  “Recruitment problems” (90% match in meaning)
• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.